Patent ID: 8852594

Claim:
A method for the treatment of a CMV infection in a subject, comprising administering to the subject a composition comprising an isolated anti-CMV antibody, or antigen-binding fragment thereof, wherein said antibody comprises: (a) a V H region comprising (i) a V H CDR1 region comprising the amino acid sequence of SSNGIH (SEQ ID NO: 57); (ii) a V H CDR2 region comprising the amino acid sequence of VISSDANDKQYADSVKG (SEQ ID NO: 58); and (iii) a V H CDR3 region comprising the amino acid sequence of DGTCSGGNCYSGLIDY (SEQ ID NO: 59); and (b) a V L region comprising (i) a V L CDR1 region comprising the amino acid sequence of RASQSVGGYLA (SEQ ID NO: 43); (ii) a V L CDR2 region comprising the amino acid sequence of ASIRAT (SEQ ID NO: 64); and (iii) a V L CDR3 region comprising the amino acid sequence of HQRSNWPPLT (SEQ ID NO: 65).